{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T14:03:37Z","timestamp":1778421817544,"version":"3.51.4"},"reference-count":46,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2009.0175","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:12:39Z","timestamp":1525252359000},"source":"Crossref","is-referenced-by-count":9,"title":["Prostatitis and Male Pelvic Pain Syndrome"],"prefix":"10.3238","author":[{"given":"Florian M. E.","family":"Wagenlehner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt G.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bschleipfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar","family":"Br\u00e4hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2009,3,13]]},"reference":[{"key":"10.3238\/arztebl.2009.0175_ref1","unstructured":"Schaeffer AJ, Anderson, RU, Krieger JN et al.: Statement on prostatitis. The assessment and management of male pelvic pain syndrome, including prostatitis. In: Edition MLUTD, editor. 6th International Conference on New Developments in Prostate Cancer and Prostate Diseases. Paris: Health Publications 2006; 343\u201375."},{"key":"10.3238\/arztebl.2009.0175_ref2","doi-asserted-by":"crossref","unstructured":"Weidner W, Schiefer HG, Krauss H et al.: Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 1991; 19 Suppl 3: 119\u201325.","DOI":"10.1007\/BF01643680"},{"key":"10.3238\/arztebl.2009.0175_ref3","doi-asserted-by":"crossref","unstructured":"Nickel JC, Downey J, Young I, Boag S: Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia. BJU Int 1999; 84(9): 976\u201381.","DOI":"10.1046\/j.1464-410x.1999.00352.x"},{"key":"10.3238\/arztebl.2009.0175_ref4","doi-asserted-by":"crossref","unstructured":"Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB: The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004; 172: 6-11; discussion 11\u20132.","DOI":"10.1097\/01.ju.0000142058.99614.ff"},{"key":"10.3238\/arztebl.2009.0175_ref5","doi-asserted-by":"crossref","unstructured":"Krieger JN, Nyberg L Jr., Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999; 282(3): 236\u20137.","DOI":"10.1001\/jama.282.3.236"},{"key":"10.3238\/arztebl.2009.0175_ref6","doi-asserted-by":"crossref","unstructured":"Millan-Rodriguez F, Palou J, Bujons-Tur A et al.: Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol 2006; 24(1): 45\u201350.","DOI":"10.1007\/s00345-005-0040-4"},{"key":"10.3238\/arztebl.2009.0175_ref7","doi-asserted-by":"crossref","unstructured":"Nickel JC, Olson ME, Costerton JW: Rat model of experimental bacterial prostatitis. Infection 1991; 19 Suppl 3: 126\u201330.","DOI":"10.1007\/BF01643681"},{"key":"10.3238\/arztebl.2009.0175_ref8","doi-asserted-by":"crossref","unstructured":"Potts JM: Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000; 164(5): 1550\u20133.","DOI":"10.1016\/S0022-5347(05)67026-7"},{"key":"10.3238\/arztebl.2009.0175_ref9","unstructured":"Meares EM, Stamey TA: Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968; 5(5): 492\u2013518."},{"key":"10.3238\/arztebl.2009.0175_ref10","doi-asserted-by":"crossref","unstructured":"Hochreiter W, Ludwig M, Weidner W et al.: National Institutes of Health (NIH) Chronic Prostatitis Symptom Index. The German version. Urologe A 2001; 40(1): 16\u20137.","DOI":"10.1007\/s001200050427"},{"key":"10.3238\/arztebl.2009.0175_ref11","doi-asserted-by":"crossref","unstructured":"Schneider H, Wilbrandt K, Ludwig M, Beutel M, Weidner W: Prostate-related pain in patients with chronic prostatitis\/chronic pelvic pain syndrome. BJU Int 2005; 95(2): 238\u201343.","DOI":"10.1111\/j.1464-410X.2005.05373.x"},{"key":"10.3238\/arztebl.2009.0175_ref12","doi-asserted-by":"crossref","unstructured":"Weidner W, Anderson RU: Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis\/chronic pelvic pain syndrome with special reference to infection\/inflammation. Int J Antimicrob Agents 2008; 31 Suppl 1: 91\u20135.","DOI":"10.1016\/j.ijantimicag.2007.07.044"},{"key":"10.3238\/arztebl.2009.0175_ref13","doi-asserted-by":"crossref","unstructured":"Penna G, Mondaini N, Amuchastegui S et al.: Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis\/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 2007; 51(2): 524\u201333; discussion 533.","DOI":"10.1016\/j.eururo.2006.07.016"},{"key":"10.3238\/arztebl.2009.0175_ref14","doi-asserted-by":"crossref","unstructured":"Ludwig M, Vidal A, Diemer T, Pabst W, Failing K, Weidner W: Chronic prostatitis\/chronic pelvic pain syndrome: seminal markers of inflammation. World J Urol 2003; 21(2): 82\u20135.","DOI":"10.1007\/s00345-003-0330-7"},{"key":"10.3238\/arztebl.2009.0175_ref15","doi-asserted-by":"crossref","unstructured":"Wesselmann U, Burnett AL, Heinberg LJ: The urogenital and rectal pain syndromes. Pain 1997; 73(3): 269\u201394.","DOI":"10.1016\/S0304-3959(97)00076-6"},{"key":"10.3238\/arztebl.2009.0175_ref16","doi-asserted-by":"crossref","unstructured":"Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID: Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001; 87(9): 797\u2013805.","DOI":"10.1046\/j.1464-410x.2001.02193.x"},{"key":"10.3238\/arztebl.2009.0175_ref17","doi-asserted-by":"crossref","unstructured":"Wagenlehner FM, Elkahwaji JE, Algaba F et al.: The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int 2007; 100(4): 733\u20137.","DOI":"10.1111\/j.1464-410X.2007.07091.x"},{"key":"10.3238\/arztebl.2009.0175_ref18","doi-asserted-by":"crossref","unstructured":"Frazier HA, Spalding TH, Paulson DF: Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain. J Urol 1992; 148: 409\u201311.","DOI":"10.1016\/S0022-5347(17)36615-6"},{"key":"10.3238\/arztebl.2009.0175_ref19","doi-asserted-by":"crossref","unstructured":"Chuang YC, Yoshimura N, Wu M et al.: Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A. Eur Urol 2007; 51(4): 1119\u201327.","DOI":"10.1016\/j.eururo.2006.11.037"},{"key":"10.3238\/arztebl.2009.0175_ref20","doi-asserted-by":"crossref","unstructured":"Bach DW, Walker H: How important are prostaglandins in the urology of man. Urol Int 1982; 37: 160\u201371.","DOI":"10.1159\/000280813"},{"key":"10.3238\/arztebl.2009.0175_ref21","unstructured":"Csef HR, Rodewig K, S\u00f6keland J: Somatoforme (funktionelle) St\u00f6rungen des Urogenitalsystems. Dtsch Arztebl 2000; 97(23): 1600\u20134."},{"key":"10.3238\/arztebl.2009.0175_ref22","doi-asserted-by":"crossref","unstructured":"Smith KB, Tripp D, Pukall C, Nickel JC: Predictors of sexual and relationship functioning in couples with Chronic Prostatitis\/Chronic Pelvic Pain Syndrome. J Sex Med 2007; 4(3): 734\u201344.","DOI":"10.1111\/j.1743-6109.2007.00466.x"},{"key":"10.3238\/arztebl.2009.0175_ref23","doi-asserted-by":"crossref","unstructured":"Stancik I, Luftenegger W, Klimpfinger M, Muller MM, Hoeltl W: Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 2004; 46(6): 760\u20134.","DOI":"10.1016\/j.eururo.2004.08.003"},{"key":"10.3238\/arztebl.2009.0175_ref24","doi-asserted-by":"crossref","unstructured":"Weidner W, Wagenlehner FM, Marconi M, Pilatz A, Pantke KH, Diemer T: Acute bacterial prostatitis and chronic prostatitis\/chronic pelvic pain syndrome: andrological implications. Andrologia 2008; 40(2): 105\u201312.","DOI":"10.1111\/j.1439-0272.2007.00828.x"},{"key":"10.3238\/arztebl.2009.0175_ref25","doi-asserted-by":"crossref","unstructured":"Ahmad I, Krishna NS: Hemospermia. J Urol 2007; 177(5): 1613\u20138.","DOI":"10.1016\/j.juro.2007.01.004"},{"key":"10.3238\/arztebl.2009.0175_ref26","unstructured":"Schaeffer AJ, Anderson RU, Krieger JN et al: Consensus statement on prostatitis. The assessment and management of male pelvic pain syndrome, including prostatitis. In: Edition MLUTD, editor. 6th International Conference on New Developments in Prostate Cancer and Prostate Diseases. Paris: Health Publications 2006: 343\u201375."},{"key":"10.3238\/arztebl.2009.0175_ref27","doi-asserted-by":"crossref","unstructured":"Schaeffer AJ, Darras FS: The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and\/or carbenicillin. J Urol 1990; 144(3): 690\u20133.","DOI":"10.1016\/S0022-5347(17)39556-3"},{"key":"10.3238\/arztebl.2009.0175_ref28","unstructured":"Peppas T, Petrikkos G, Deliganni V, Zoumboulis P, Koulentianos E, Giamarellou H: Efficacy of long-term therapy with norfloxacin in chronic bacterial prostatitis. J Chemother 1989; 1(Suppl 4): 867\u20138."},{"key":"10.3238\/arztebl.2009.0175_ref29","unstructured":"Pust RA, Ackenheil-Koppe HR, Gilbert P, Weidner W: Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results. J Chemother 1989; 1(Suppl 4): 869\u201371."},{"key":"10.3238\/arztebl.2009.0175_ref30","doi-asserted-by":"crossref","unstructured":"Weidner W, Schiefer HG, Dalhoff A: Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study. Am J Med 1987; 82: 280\u20133.","DOI":"10.1016\/S0022-5347(17)76202-7"},{"key":"10.3238\/arztebl.2009.0175_ref31","doi-asserted-by":"crossref","unstructured":"Weidner W, Schiefer HG, Brahler E: Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol 1991; 146: 350\u20132.","DOI":"10.1016\/S0022-5347(17)37791-1"},{"key":"10.3238\/arztebl.2009.0175_ref32","doi-asserted-by":"crossref","unstructured":"Pfau A: The treatment of chronic bacterial prostatitis. Infection 1991; 3(Suppl 19): 160\u20134.","DOI":"10.1007\/BF01643689"},{"key":"10.3238\/arztebl.2009.0175_ref33","doi-asserted-by":"crossref","unstructured":"Naber KG, Busch W, Focht J: Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int J Antimicrob Agents 2000; 14: 143\u20139.","DOI":"10.1016\/S0924-8579(99)00142-9"},{"key":"10.3238\/arztebl.2009.0175_ref34","doi-asserted-by":"crossref","unstructured":"Naber KG: Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents 2002; 20: 18\u201327.","DOI":"10.1016\/S0924-8579(02)00067-5"},{"key":"10.3238\/arztebl.2009.0175_ref35","doi-asserted-by":"crossref","unstructured":"Bundrick W, Heron SP, Ray P et al.: Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology 2003; 62: 537\u201341.","DOI":"10.1016\/S0090-4295(03)00565-X"},{"key":"10.3238\/arztebl.2009.0175_ref36","doi-asserted-by":"crossref","unstructured":"Naber KG, Roscher K, Botto H, Schaefer V: Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents 2008; 32: 145\u201353.","DOI":"10.1016\/j.ijantimicag.2008.03.014"},{"key":"10.3238\/arztebl.2009.0175_ref37","doi-asserted-by":"crossref","unstructured":"Nickel JC, Downey J, Clark J et al.: Levofloxacin for chronic prostatitis\/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003; 62: 614\u20137.","DOI":"10.1016\/S0090-4295(03)00583-1"},{"key":"10.3238\/arztebl.2009.0175_ref38","doi-asserted-by":"crossref","unstructured":"Cheah PY, Liong ML, Yuen KH et al.: Terazosin therapy for chronic prostatitis\/chronic pelvic pain syndrome: a randomized placebo controlled trial. J Urol 2003; 169: 592\u20136.","DOI":"10.1016\/S0022-5347(05)63960-2"},{"key":"10.3238\/arztebl.2009.0175_ref39","doi-asserted-by":"crossref","unstructured":"Mehik A, Alas P, Nickel JC, Sarpola A, Helstrom PJ: Alfuzosin treatment for chronic prostatitis\/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled pilot study. Urology 2003; 62: 425\u20139.","DOI":"10.1016\/S0090-4295(03)00466-7"},{"key":"10.3238\/arztebl.2009.0175_ref40","doi-asserted-by":"crossref","unstructured":"Nickel JC, Narayan P, McKay J, Doyle C: Treatment of chronic prostatitis\/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004; 171: 1594\u20137.","DOI":"10.1097\/01.ju.0000117811.40279.19"},{"key":"10.3238\/arztebl.2009.0175_ref41","doi-asserted-by":"crossref","unstructured":"Alexander RB, Propert KJ, Schaeffer AJ et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized double-blind trial. Ann Intern Med 2004; 141: 581\u20139.","DOI":"10.7326\/0003-4819-141-8-200410190-00005"},{"key":"10.3238\/arztebl.2009.0175_ref42","doi-asserted-by":"crossref","unstructured":"Nickel JC, Pontari M, Moon T et al.: A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003; 169: 1401\u20135.","DOI":"10.1097\/01.ju.0000054983.45096.16"},{"key":"10.3238\/arztebl.2009.0175_ref43","doi-asserted-by":"crossref","unstructured":"Nickel JC, Johnston B, Downey J et al.: Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial. Urology 2000; 56: 413\u20137.","DOI":"10.1016\/S0090-4295(00)00685-3"},{"key":"10.3238\/arztebl.2009.0175_ref44","doi-asserted-by":"crossref","unstructured":"Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI: A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004; 93: 991\u20135.","DOI":"10.1111\/j.1464-410X.2003.04766.x"},{"key":"10.3238\/arztebl.2009.0175_ref45","doi-asserted-by":"crossref","unstructured":"De Rose AF, Gallo F, Giglio M, Carmignani G: Role of mepartricin in category III chronic nonbacterial prostatitis\/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology 2004; 63: 13\u20136.","DOI":"10.1016\/j.urology.2003.08.006"},{"key":"10.3238\/arztebl.2009.0175_ref46","doi-asserted-by":"crossref","unstructured":"Shoskes DA, Zeitlin SI, Shahed A, Rajfer J: Quercetin in men with category III chronic prostatitis: a preliminary prospective double-blind placebo-controlled trial. Urology 1999; 54: 960\u20133.","DOI":"10.1016\/S0090-4295(99)00358-1"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2009.0175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T09:29:30Z","timestamp":1638869370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2009.0175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,13]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2009.0175","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,13]]}}}